ENCOURAGING OUTCOMES OF SECOND ALLOGENEIC STEM CELL TRANSPLANT FOR ACUTE LEUKEMIAS AND MYELODYSPLASTIC SYNDROMES FROM TWO CENTERS IN SÃO PAULO, BRAZIL

Objectives: Second allogeneic Hematopoietic Stem Cell Transplant (HSCT) is the only curative treatment option for patients who relapse after a first transplant for malignant diseases. Previously reported outcomes for this intervention are often dismal, with high Relapse Incidence (RI), Non-Relapse M...

Full description

Bibliographic Details

Published in:	Hematology, Transfusion and Cell Therapy
Main Authors:	EL Rosa, FS Azevedo, CC Justino, AM Fonseca, PHA Moraes, VC Molla, RS Szor, CD Liz, AG Guerra, MM Almeida, GMC Silva, CF Oliveira, TFN Araújo, LPDS Rocha, ML Puls, C Arrais
Format:	Article
Language:	English
Published:	Elsevier 2024-10-01
Online Access:	http://www.sciencedirect.com/science/article/pii/S2531137924021023